Our results point to IL-10 as a major candidate effector of tumor-related modulation of DC subset migration from human skin, resulting in prevailing migration of CD14+BDCA3/CD141+ DC that acquire an immunoregulatory phenotype and cytokine release profile with detrimental effects on cell-mediated immunity. The gene discussed is IL10; the disease is neoplasm.